Cargando…
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease worldwide. Chronic hyperglycemia and high blood pressure are the main risk factors for the development of DN. In general, screening for microalbuminuria should be performed annually, starting 5 years after diagnosis in type 1...
Autor principal: | Samsu, Nur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285185/ https://www.ncbi.nlm.nih.gov/pubmed/34307650 http://dx.doi.org/10.1155/2021/1497449 |
Ejemplares similares
-
Pathogenesis of diabetic nephropathy
por: Cao, Zemin, et al.
Publicado: (2011) -
Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
por: Samsu, Nur, et al.
Publicado: (2019) -
Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013) -
Epigenetics in the pathogenesis of diabetic nephropathy: Epigenetics in the pathogenesis of diabetic nephropathy
por: Li, Xue, et al.
Publicado: (2021) -
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
por: Mashitah, Musthika Wida, et al.
Publicado: (2015)